Inhibition of HDAC1 has an endothelial-protective effect in pre-clinical model of ALI, and compounds with selective HDAC1/2 inhibitory properties may have a therapeutic potential in ALI/ARDS treatment. Here, HDAC1 is linked to acute respiratory distress syndrome.